Innovent Biologics Inks Potential 105 Billion Drug Deal with Pfizer DUOL Q1 2026 Earnings EPS Crushes Estimates as User Growth Momentum Continues Novartis Raises FullYear Sales and Profit Guidance Citing Strong Operational Momentum